Inclusion Criteria:
  1. Adults ≥ 18 years old
  2. High risk for cardiovascular morbidity and mortality such as prior history of clinical cardiovascular disease and/or history of familial hypercholesterolemia
  3. LDL-C within the past 6 months above recommended level despite maximal tolerated statin therapy ± ezetimibe for the past 3 months.
Exclusion Criteria:
  1. Current treatment with PCSK9 inhibitor
  2. Current participation in investigational study
  3. Prior participation in the GOAL program